Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial

Keyphrases

• Pregnant Women 100%
• Randomized Controlled Trial 100%
• Anemia 100%
• Nigeria 100%
• Oral Iron 100%
• Oral Ferrous Sulfate 80%
• Iron Deficiency 60%
• Ferric Carboxymaltose 60%
• Gestational Age 40%
• Preterm Birth 40%
• Adverse Events 40%
• No Significant Difference 40%
• Intravenous Iron 40%
• Postpartum Visit 40%
• Sulfate Group 40%
• Rheumatoid Arthritis 20%
• Diarrhea 20%
• Web-based 20%
• Headache 20%
• Intravenous Administration 20%
• Oral Administration 20%
• Hemoglobin 20%
• Blood Transfusion 20%
• Systemic Lupus Erythematosus 20%
• Major Surgery 20%
• Hemoglobin Concentration 20%
• Vomiting 20%
• Vaginal Bleeding 20%
• Risk Ratio 20%
• Exclusion Criteria 20%
• Maternal Depression 20%
• Intention-to-treat 20%
• Malabsorption 20%
• Maternal Anemia 20%
• Anemia in Pregnancy 20%
• Lagos 20%
• Elemental Iron 20%
• Immune Disease 20%
• Poor Adherence 20%
• Kano 20%
• Bill & Melinda Gates Foundation 20%
• Transfusion-surgery 20%
• Anemic Pregnant Women 20%
• Serious Mental Illness 20%
• Well Tolerated 20%
• Ineligibility 20%
• Symptomatic Anemia 20%
• Secondary Care Centres 20%
• Severe Allergic Reaction 20%
• Tertiary Health Facilities 20%

Medicine and Dentistry

• Randomized Controlled Trial 100%
• Anemia 100%
• Oral 100%
• Pregnant Woman 100%
• Ferrous Sulfate 44%
• Iron Deficiency 33%
• Ferric Carboxymaltose 33%
• Adverse Event 22%
• Premature Labor 22%
• Gestational Age 22%
• Rheumatoid Arthritis 11%
• Nurse 11%
• Single Drug Dose 11%
• Prevalence 11%
• Oral Drug Administration 11%
• Postpartum Depression 11%
• Diarrhea 11%
• Blood Transfusion 11%
• Hypersensitivity 11%
• Intention-to-Treat Analysis 11%
• Allergic Response 11%
• Headache 11%
• Malabsorption 11%
• Hemoglobin Determination 11%
• Vagina Bleeding 11%
• Major Surgery 11%
• Systemic Lupus Erythematosus 11%
• Hemoglobins 11%
• Inflammatory Arthritis 11%
• Diseases 11%
• Exclusion Criterion 11%
• Neurodevelopmental Disorder 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Randomized Controlled Trial 100%
• Anemia 100%
• Ferrous Sulfate 50%
• Ferric Carboxymaltose 37%
• Iron Deficiency 37%
• Premature Labor 25%
• Adverse Event 25%
• Hemoglobins 25%
• Erethism 12%
• Diarrhea 12%
• Headache 12%
• Rheumatoid Arthritis 12%
• Prevalence 12%
• Postnatal Depression 12%
• Vagina Bleeding 12%
• Malabsorption 12%
• Systemic Lupus Erythematosus 12%
• Inflammatory Arthritis 12%
• Diseases 12%
• Oral Administration 12%
• Mental Diseases 12%